✦ LIBER ✦

PCV12 COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN ETEXILATE VERSUS ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE

✍ Scribed by Fernandes, RA; Quintella, FF; Teich, VD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV15 COST-EFFECTIVENESS ANALYSIS OF DAB

✍ Fernandes, RA; Quintella, FF; Teich, VD 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Dabigatran etexilate versus enoxaparin f

✍ Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 130 KB

PCV39 COST-EFFECTIVENESS OF DABIGATRAN E

✍ C Mateus; S Wolowacz; JA Pereira 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PCV56 Cost-Effectiveness of Dabigatran E

✍ V. Nasciben; M.J.D.O. Figueiredo; F.C.D.C. Darrieux; L.S.P. Piegas; S.C.O. Marti 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB